Ashok Venkitaraman | |
|---|---|
| Alma mater | |
| Awards |
|
| Website | https://www.csi.nus.edu.sg/web/ashok-venkitaraman/ https://www.mrc-cu.cam.ac.uk/research/ashok-venkitaraman-folder |
| Academic career | |
| Fields | Immunology, Oncology, Molecular biology, Chemical biology |
| Institutions | Cancer Science Institute of Singapore
National University of Singapore A*STAR Singapore Medical Research Council (MRC) Cancer Unit University of Cambridge MRC Laboratory of Molecular Biology |
| Thesis | The regulation of MHC class 2 gene expression by tumours of the B lymphocyte lineage |
| Doctoral advisor | Marc Feldmann |
Ashok Venkitaraman is a British cancer researcher of Indian origin. He is the Director of the Cancer Science Institute of Singapore, a Distinguished Professor of Medicine at the National University of Singapore, and Program Director at A*STAR, Singapore.[1] From 1998 to 2020, he was the inaugural holder of the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, a Professorial Fellow at Pembroke College, Cambridge, and from 2006 to 2019, was the Director of the Medical Research Council Cancer Unit.[2][3][4]
- ^ "Prominent cancer researcher Ashok Venkitaraman to head Cancer Science Institute of Singapore at NUS".
- ^ "MRC Cancer Unit Professor Ashok Venkitaraman biography".
- ^ "Venkitaraman, Prof. Ashok. UK WHOS WHO. 2017". doi:10.1093/ww/9780199540884.013.41050. ISBN 978-0-19-954088-4.
- ^ "Fellows and College Officers, Pembroke College Cambridge".